Peter Goadsby
Peter Goadsby
Peter Goadsby obtained his medical degree and training at the University of New South Wales (UNSW), Australia. His PhD in neural mechanisms involved in headache disorders and his Neurology training was with James W. Lance. His clinical neurophysiology training was with David Burke. He is currently Professor of Neurology, University of California, Los Angeles and Director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College London. He was elected a Fellow of the Royal Society in 2022
He has studied headache disorders from bench to bedside, collaborating with Lars Edvinsson to be the first to show the involvement of CGRP in migraine and cluster headache, which led directly to the development of gepants and CGRP monoclonal antibody treatments for migraine. He has explored migraine and cluster headache mechanisms with laboratory models, human experimental medicine, functional brain imaging and clinical trials, while maintaining an active clinical practice that focuses his efforts on real translational benefits for patients with headache disorders.
The Brain Prize 2021 is also awarded to:
